Phibro Animal Health | PAHC - 营业费用

金融业

USD

USD 1.41B

现金及等价物

USD 55.49M

USD 240.42M

USD 862.19M

USD 282.37M

USD 474.17M

股息收益率

1.29

USD 54.99M

USD 68.1M

1.92K

EPS每股收益

USD 0.78

股本和储备

USD 332.36M

USD 133.5M

债务利息支出

USD 11.91M

USD 0.08

USD 603.6M

USD 2.34B

USD 27.46M

USD 332.36M

USD 54.99M

普通股股本

USD 40.48M

13.82

USD 38.63M

USD 373.91M

销售和管理费用

USD 78.32M

USD 517.35M

贸易债权人

USD 133.3M

应收帐款人

USD 215.87M

	营业费用	更改		日
Align Technology	USD 822.85M		11.8M	2025-12
ANI Pharmaceuticals	USD 217.93M		287.88M	2025-12
Assertio Holdings	USD 105.8M		12.5M	2025-09
Aurora Cannabis	CAD 129.98M		16.05M	2025-12
Bristol-Myers Squibb	USD 8.3B		10.25B	2025-12
Canopy Growth	CAD 87.2M		6.22M	2025-12
Corcept Therapeutics	USD 197.64M		219K	2025-12
Eli Lilly	USD 10.31B		1.09B	2025-12
Henry Schein	USD 3.25B		110M	2025-12
Idexx Laboratories	USD 774.97M		24.58M	2025-12
Knight Therapeutics	CAD 126.9M		8.29M	2025-12
Merck	USD 10.16B		558M	2025-12
Nektar Therapeutics	USD 40.9M		44.19M	2025-12
Pacira	USD 193.68M		27.32M	2025-12
Phibro Animal Health	USD 332.36M		20.68M	2025-12
Prestige Brands	USD 200.95M		6.51M	2025-12
Supernus Pharmaceuticals	USD 197.75M		54.54M	2025-12
Zoetis	USD 1.55B		3.85B	2025-12